The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Read More…
Industry, Sector and Symbol
Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Phone925-460-3600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.53 billion
Profitability
Miscellaneous
Employees12,000
Next Earnings Date12/5/2019 (Confirmed)
OptionableOptionable
Cooper Companies (NYSE:COO) Frequently Asked Questions
What is Cooper Companies' stock symbol?
Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."
How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?
Cooper Companies announced a Semi-Annual dividend on Wednesday, July 10th. Shareholders of record on Tuesday, July 23rd will be given a dividend of $0.03 per share on Wednesday, August 7th. The ex-dividend date is Monday, July 22nd. View Cooper Companies' Dividend History.
How were Cooper Companies' earnings last quarter?
Cooper Companies Inc (NYSE:COO) announced its earnings results on Thursday, August, 29th. The medical device company reported $3.23 earnings per share for the quarter, beating the Zacks' consensus estimate of $3.16 by $0.07. The medical device company had revenue of $679.40 million for the quarter, compared to analyst estimates of $687.60 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. The firm's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.00 EPS. View Cooper Companies' Earnings History.
When is Cooper Companies' next earnings date?
How can I listen to Cooper Companies' earnings call?
Cooper Companies will be holding an earnings conference call on Thursday, December 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Cooper Companies issued on next quarter's earnings?
Cooper Companies updated its FY19 earnings guidance on Thursday, August, 29th. The company provided earnings per share (EPS) guidance of $12.27-12.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.28. The company issued revenue guidance of $2.635-2.655 billion, compared to the consensus revenue estimate of $2.65 billion.
What price target have analysts set for COO?
11 analysts have issued 1-year price objectives for Cooper Companies' stock. Their forecasts range from $221.00 to $365.00. On average, they anticipate Cooper Companies' stock price to reach $325.00 in the next year. This suggests a possible upside of 6.7% from the stock's current price. View Analyst Price Targets for Cooper Companies.
What is the consensus analysts' recommendation for Cooper Companies?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 1 sell rating, 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies.
Has Cooper Companies been receiving favorable news coverage?
Media headlines about COO stock have been trending very negative on Wednesday, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cooper Companies earned a news impact score of -3.9 on InfoTrie's scale. They also gave news stories about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Cooper Companies.
Are investors shorting Cooper Companies?
Cooper Companies saw a decrease in short interest during the month of October. As of October 31st, there was short interest totalling 945,600 shares, a decrease of 7.3% from the September 30th total of 1,020,000 shares. Based on an average daily volume of 307,800 shares, the days-to-cover ratio is presently 3.1 days. Currently, 1.9% of the company's stock are sold short. View Cooper Companies' Current Options Chain.
Who are some of Cooper Companies' key competitors?
Some companies that are related to Cooper Companies include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Anika Therapeutics (ANIK), Antares Pharma (ATRS), Cerus (CERS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).
What other stocks do shareholders of Cooper Companies own?
Who are Cooper Companies' key executives?
Cooper Companies' management team includes the folowing people:
- Mr. Albert G. White III, Pres, CEO & Director (Age 49)
- Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 40)
- Mr. Daniel G. McBride, Exec. VP & COO (Age 55)
- Ms. Holly R. Sheffield, Exec. VP & Chief Strategy Officer (Age 48)
- Dr. Robert D. Auerbach, Pres of Coopersurgical Inc (Age 58)
Who are Cooper Companies' major shareholders?
Cooper Companies' stock is owned by many different of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (4.01%), Veritas Asset Management LLP (2.00%), California Public Employees Retirement System (0.80%), WCM Investment Management LLC (0.75%), Findlay Park Partners LLP (0.67%) and Handelsbanken Fonder AB (0.62%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Institutional Ownership Trends for Cooper Companies.
Which institutional investors are selling Cooper Companies stock?
COO stock was sold by a variety of institutional investors in the last quarter, including Findlay Park Partners LLP, Massachusetts Financial Services Co. MA, Public Employees Retirement Association of Colorado, Sawgrass Asset Management LLC, BB&T Securities LLC, Fisher Asset Management LLC, Mackay Shields LLC and Congress Asset Management Co. MA. Company insiders that have sold Cooper Companies company stock in the last year include Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.
Which institutional investors are buying Cooper Companies stock?
COO stock was purchased by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., California Public Employees Retirement System, State of Alaska Department of Revenue, WCM Investment Management LLC, State of Tennessee Treasury Department, Russell Investments Group Ltd., Veritas Asset Management LLP and James Hambro & Partners. View Insider Buying and Selling for Cooper Companies.
How do I buy shares of Cooper Companies?
Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cooper Companies' stock price today?
One share of COO stock can currently be purchased for approximately $304.47.
How big of a company is Cooper Companies?
Cooper Companies has a market capitalization of $15.09 billion and generates $2.53 billion in revenue each year. The medical device company earns $139.90 million in net income (profit) each year or $11.50 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe.View Additional Information About Cooper Companies.
What is Cooper Companies' official website?
How can I contact Cooper Companies?
Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]
MarketBeat Community Rating for Cooper Companies (NYSE COO)
MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days.
